NCT06437587

Brief Summary

The goal of this clinical trial is to assess the effect of S-HRAT to improve patients' motor function and activities of daily living.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 23, 2024

Status Verified

September 1, 2024

Enrollment Period

4 months

First QC Date

May 25, 2024

Last Update Submit

September 19, 2024

Conditions

Keywords

home-based rehabilitationappropriate technology

Outcome Measures

Primary Outcomes (2)

  • Motor Function

    The motor function of the patients is measured using the Motor Assessment Scale (MAS) for stroke. MAS is methodologically simple, targeted, and easily generalizable for motor function assessment in stroke patients, as well as reliable and valid. The scale consists of nine items, each of which is scored from 0 to 6 out of 48, with the ninth item not scoring. Higher scores indicate better motor function.

    baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).

  • Balance

    Balance was measured using the Berg Balance Scale (BBS). The scale consists of 14 items, including sitting to standing, standing independently, walking independently, and standing to sit, and each item is scored on five functional levels: 0, 1, 2, 3, and 4. A score of 4 indicates that the action under examination can be performed normally. In contrast, a score of 0 indicates that it cannot be performed or requires significant assistance. The total possible score is 56, with higher scores indicating better balance.

    baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).

Secondary Outcomes (4)

  • Activity of Daily Living

    baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).

  • Exercise Adherence

    baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).

  • Patient Satisfaction

    baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).

  • Anxiety and Depression

    baseline (T0), 8-week post-intervention (T1), and 12-week follow-up (T2).

Study Arms (2)

intervention group

EXPERIMENTAL

Home-based rehabilitation appropriate technology (S-HRAT) training

Other: Home-based rehabilitation appropriate technology (S-HRAT) training

control group

NO INTERVENTION

Routine discharge instructions

Interventions

The S-HRAT training instruction consists of two phases: in-hospital training and post-discharge remote home training. Based on the S-HRAT list, we select individualized home rehabilitation training exercises for the participants and conduct five offline training instruction sessions one week before discharge to ensure that the participants master the correct method for each exercise and clarify precautions. At discharge, participants will receive an S-HRAT brochures, which will include detailed text, pictures and video demonstrations of exercises, to visualize the rehabilitation instructions and make them easy to understand. Participants learn how to use the S-HRAT booklet and follow a daily training program to complete the prescribed content. They will be asked to record a video of their training and send it to the researcher via WeChat for monitoring purposes and feedback.

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥18;
  • Patients diagnosed with cerebrovascular disease who have cerebral infarction or cerebral hemorrhage based on cranial CT or MRI and meet the diagnostic criteria;
  • Patients are in the non-acute phase, meaning between two weeks and six months after the onset of the disease;
  • Patients with limb dysfunction.

You may not qualify if:

  • Return to a hospital or rehabilitation facility after discharge;
  • The patient has a history of mental illness and dyslexia;
  • Patients have a combination of serious, life-threatening conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Daqing Oilfield General Hospital

Daqing, Heilongjiang, 163001, China

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Due to the nature of the intervention, it is impossible to blind the researcher of the intervention who will deliver the intervention. Therefore, the participants and the outcome assessor will be blinded. The outcome assessor will be blinded to the allocation throughout the study and will independently assess all outcomes at T0, T1, and T2 for both groups.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
researcher

Study Record Dates

First Submitted

May 25, 2024

First Posted

May 31, 2024

Study Start

June 1, 2024

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

September 23, 2024

Record last verified: 2024-09

Locations